These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 22089317)

  • 21. Cognitive deficits among methamphetamine users with attention deficit hyperactivity disorder symptomatology.
    Sim T; Simon SL; Domier CP; Richardson K; Rawson RA; Ling W
    J Addict Dis; 2002; 21(1):75-89. PubMed ID: 11831502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of relapse on cognition in abstinent methamphetamine abusers.
    Simon SL; Dacey J; Glynn S; Rawson R; Ling W
    J Subst Abuse Treat; 2004 Jul; 27(1):59-66. PubMed ID: 15223095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Social-cognitive difficulties in former users of methamphetamine.
    Henry JD; Mazur M; Rendell PG
    Br J Clin Psychol; 2009 Sep; 48(Pt 3):323-7. PubMed ID: 19397848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methamphetamine-induced neural and cognitive changes in rodents.
    Marshall JF; Belcher AM; Feinstein EM; O'Dell SJ
    Addiction; 2007 Apr; 102 Suppl 1():61-9. PubMed ID: 17493054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropsychological comparisons of cocaine versus methamphetamine users: A research synthesis and meta-analysis.
    Hall MG; Hauson AO; Wollman SC; Allen KE; Connors EJ; Stern MJ; Kimmel CL; Stephan RA; Sarkissians S; Barlet BD; Grant I
    Am J Drug Alcohol Abuse; 2018; 44(3):277-293. PubMed ID: 28825847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longer term improvement in neurocognitive functioning and affective distress among methamphetamine users who achieve stable abstinence.
    Iudicello JE; Woods SP; Vigil O; Scott JC; Cherner M; Heaton RK; Atkinson JH; Grant I;
    J Clin Exp Neuropsychol; 2010 Aug; 32(7):704-18. PubMed ID: 20198527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions.
    Lundqvist T
    Pharmacol Biochem Behav; 2005 Jun; 81(2):319-30. PubMed ID: 15925403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of prenatal methamphetamine exposure: a review of cognitive and neuroimaging studies.
    Kwiatkowski MA; Roos A; Stein DJ; Thomas KG; Donald K
    Metab Brain Dis; 2014 Jun; 29(2):245-54. PubMed ID: 24370774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive deficits in methamphetamine addiction: Independent contributions of dependence and intelligence.
    Fitzpatrick RE; Rubenis AJ; Lubman DI; Verdejo-Garcia A
    Drug Alcohol Depend; 2020 Apr; 209():107891. PubMed ID: 32061948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low dose, short-term rivastigmine administration does not affect neurocognition in methamphetamine dependent individuals.
    Kalechstein AD; Yoon JH; Croft DE; Jaeggi S; Mahoney JJ; De La Garza R
    Pharmacol Biochem Behav; 2011 Sep; 99(3):423-7. PubMed ID: 21624391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A meta-analysis of the relationship between abstinence and neuropsychological functioning in methamphetamine use disorder.
    Basterfield C; Hester R; Bowden SC
    Neuropsychology; 2019 Jul; 33(5):739-753. PubMed ID: 31021107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug abstinence and cognitive control in methamphetamine-dependent individuals.
    Salo R; Nordahl TE; Galloway GP; Moore CD; Waters C; Leamon MH
    J Subst Abuse Treat; 2009 Oct; 37(3):292-7. PubMed ID: 19339145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methamphetamine use parameters do not predict neuropsychological impairment in currently abstinent dependent adults.
    Cherner M; Suarez P; Casey C; Deiss R; Letendre S; Marcotte T; Vaida F; Atkinson JH; Grant I; Heaton RK;
    Drug Alcohol Depend; 2010 Jan; 106(2-3):154-63. PubMed ID: 19815352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Denial in methamphetamine users: Associations with cognition and functional connectivity in brain.
    Dean AC; Kohno M; Morales AM; Ghahremani DG; London ED
    Drug Alcohol Depend; 2015 Jun; 151():84-91. PubMed ID: 25840750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective memory impairment in former users of methamphetamine.
    Rendell PG; Mazur M; Henry JD
    Psychopharmacology (Berl); 2009 Apr; 203(3):609-16. PubMed ID: 19037633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurocognitive deficits are associated with unemployment in chronic methamphetamine users.
    Weber E; Blackstone K; Iudicello JE; Morgan EE; Grant I; Moore DJ; Woods SP;
    Drug Alcohol Depend; 2012 Sep; 125(1-2):146-53. PubMed ID: 22560676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropsychological function and delay discounting in methamphetamine-dependent individuals.
    Hoffman WF; Moore M; Templin R; McFarland B; Hitzemann RJ; Mitchell SH
    Psychopharmacology (Berl); 2006 Oct; 188(2):162-70. PubMed ID: 16915378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The acute effects of 3,4-methylenedioxymethamphetamine and d-methamphetamine on human cognitive functioning.
    Stough C; King R; Papafotiou K; Swann P; Ogden E; Wesnes K; Downey LA
    Psychopharmacology (Berl); 2012 Apr; 220(4):799-807. PubMed ID: 22020992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methamphetamine-associated difficulties in cognitive control allocation may normalize after prolonged abstinence.
    Stock AK; Rädle M; Beste C
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jan; 88():41-52. PubMed ID: 29953935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.